Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Dear Editor, As of June, 2020, more than ten million cases of COVID-19 have been reported worldwide. The causative pathogen of the disease is a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (World Health Organization, 2020). Animal infection models are important to characterize the infection, pathogenesis, and immunology of SARS-CoV-2, as well as for the development of medications and vaccines against COVID-19. Mice are particularly attractive animal models for their identical genetic background, reliable reproducibility, well characterized biology, and the huge availability of research reagents and knockout animals. Models in inbreed mice such as BALB/c and C57BL/6J (C57), which are widely used in research, are highly desired. The ideal model should mimic the infection of SARS-CoV-2 in humans, in whom the virus efficiently replicates in both the upper and lower respiratory tracts. Several SARS-CoV-2 mouse infection models, including human angiotensin-converting enzyme 2 (ACE2) transgenic mouse models (Bao et al., 2020; Jiang et al., 2020), a BALB/c mouse-adapted virus model (Gu et al., 2020), a reverse genetically modified SARS-CoV-2 infection model (Dinnon III et al., 2020), and recombinant adenovirus-mediated transient expression of human ACE2 mouse models (Hassan et al., 2020; Sun et al., 2020), have been reported that viruses efficiently replicated in the lung. However, none of these reported models showed significant and stable infection in the upper respiratory tract. SARS-CoV-2 infection of the upper respiratory tract in humans is highly associated with the initial infection, the shedding of the offspring virus, and the transmission capability of the disease. Prevention of virus replication in the upper and lower respiratory tract is, therefore, highly desirable and an important aspect of the development of antiviral medications and vaccines against COVID-19. The mouse-adapted virus infected mouse model established here resembling the infection of SARS-CoV-2 in humans will be helpful to achieve the goals. Firstly, we found SARS-CoV-2/HRB26/human/2020/CHN (HRB26) is able to establish infection in the respiratory tract of BALB/c mice (Fig. S1). 4–6-week-old female BALB/c mice were intranasally (i.n.) infected with HRB26 at a dose of 106.2 plaque forming unit (PFU). On day 3 post inoculation (p.i.), the nasal turbinates and lungs were respectively collected and homogenized for viral RNA detection by qPCR and virus titration in Vero E6 cells. HRB26 only infected the nasal turbinates of 2 of the 3 inoculated mice and the lung of 1 of the 3 inoculated mice (Fig. S1). We serially passaged HRB26 in 4–6-week-old female BALB/c mice. A mixture of nasal turbinate and lung homogenate from the mouse of each passage with the highest viral RNA copies was used to inoculate three mice via intranasal inoculation. The viral RNA loads increased by passages in the nasal turbinates (Fig. S1A) and lungs (Fig. S1B). The infectious titres in the nasal turbinates and lungs at passage 14 (P14) were 105 PFU/g and 106.7 PFU/g on day 3 p.i., respectively (Fig. S1C and S1D). The virus of P14 was propagated in Vero E6 cells and the resultant mouse-adapted virus was designated as HRB26M (105.7 PFU/mL). The 50% mouse infectious dose (MID50) of HRB26M in 4–6-week-old female BALB/c mice was 1.4 PFU (Fig. S2). In the mice infected i.n. with HRB26M, the viral RNA was detected in the nasal turbinates on day 3, 5, and 7 p.i., and the infectious virus was detected on day 3 and 5 p.i. (Fig. 1A and 1B). The viral RNA was also detected in the heart, liver, kidney and spleen on day 3 p.i., but not on day 5 and day 7 p.i., respectively (Fig. S3A and S3B). Characterization of Mouse-adapted SARS-CoV-2 HRB26M in mice. Groups of nine 4–6-week-old female BALB/c mice (A, B), 4–6-week-old female C57 mice (C, D) or 8–9-week-old male BALB/c mice (E, F) were inoculated i.n. with 104.4 PFU of HRB26M in a volume of 50 μL. On days 3, 5, and 7 p.i., three mice were each euthanized, and their nasal turbinates and lungs were collected for virus detection. The viral RNA copies (A, C, E) and infectious titres (B, D, F) in each organ were detected by qPCR and virus titration. The horizontal dashed lines indicate the limit of detection. Histopathologic and immunohistochemical studies were performed on samples from the HRB26M-inoculated young female mice (G–L) and aging adult male mice (M–R). The nasal respiratory mucosa epithelium exhibited an abnormal arrangement with loss of cilia accompanied by monocyte and lymphocyte infiltration in the lamina propria on day 3 p.i. (G). Diffuse degeneration of the epithelial cells of the bronchiole and moderate peripheral inflammatory cell infiltration were observed on day 5 p.i. (H). Congestion in the interalveolar septa and perivascular edema were commonly observed in the lungs on day 3 p.i. (I). Viral antigen was detected in the epithelium of the nasal respiratory mucosa (J), the epithe
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Bao, L., Deng, W., Huang, B., Gao, H., Liu, J., Ren, L., Wei, Q., Yu, P., Xu, Y., Qi, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2312-y · Cited by 1,126
Self-citationAdaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., et al. (2020) · Science · doi:10.1126/science.abc4730 · Cited by 762
Self-citationA mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Dinnon, K. H., Leist, S. R., Schäfer, A., Edwards, C. E., Martinez, D. R., Montgomery, S. A., West, A., Yount, B. L., Hou, Y. J., Adams, L. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2708-8 · Cited by 675
Cited by
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
Leist, S. R., Dinnon, K. H., Schäfer, A., Tse, L. V., Okuda, K., Hou, Y. J., West, A., Edwards, C. E., Sanders, W., Fritch, E. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.050 · Cited by 613
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
Wong, L.-Y. R., Zheng, J., Wilhelmsen, K., Li, K., Ortiz, M. E., Schnicker, N. J., Thurman, A., Pezzulo, A. A., Szachowicz, P. J., Li, P., et al. (2022) · Nature · doi:10.1038/s41586-022-04630-3 · Cited by 178
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice
Huang, K., Zhang, Y., Hui, X., Zhao, Y., Gong, W., Wang, T., Zhang, S., Yang, Y., Deng, F., Zhang, Q., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103381 · Cited by 119
“Several mouse-adapted SARS-CoV-2 strains, such as MASCp6 (N501Y), MA10 (Q493K) and HRB26 (Q498H), increase virulence or replication in mice likely attributed to one of the mutations in the S protein [15,26,45,46].”
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
Sun, S., Gu, H., Cao, L., Chen, Q., Ye, Q., Yang, G., Li, R.-T., Fan, H., Deng, Y.-Q., Song, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25903-x · Cited by 104
Self-citationAnimal models in SARS-CoV-2 research
Chu, H., Chan, J. F.-W., & Yuen, K.-Y. (2022) · Nature Methods · doi:10.1038/s41592-022-01447-w · Cited by 103
Metadata
- Authors
- Wang, J., Shuai, L., Wang, C., Liu, R., He, X., Zhang, X., Sun, Z., Shan, D., Ge, J., Wang, X., Hua, R., Zhong, G., Wen, Z., & Bu, Z.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-04
- Volume
- 11
- Issue
- 10
- Pages
- 776-782
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W3047617849
- Cited by
- 95
- References
- 4
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. https://app.cochat.ai/papers/10.1007/s13238-020-00767-x
- The paper
- Wang, J., Shuai, L., Wang, C., Liu, R., He, X., Zhang, X., Sun, Z., Shan, D., Ge, J., Wang, X., Hua, R., Zhong, G., Wen, Z., & Bu, Z. (2020). Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein & Cell. https://doi.org/10.1007/s13238-020-00767-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.